RxDoctor Payments Data

Dakota Acton-Jones, MD

Family Medicine · Fayette, ALNPI 1790167864

Payments from drug & device makers

$1,209in general payments, 2019–2025

Across 71 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$207
  • Lilly USA, LLC$187
  • Amgen$181
  • Astellas Pharma US Inc$127
  • Pfizer$96
  • Daiichi Sankyo Inc.$65
  • plus $345 from 13 others

What the payments were for

  • Food & beverage$1,10992%
  • Education$1008%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,209 in reported general payments places this provider in the 60th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$83,821
Medicare patients
187
Services billed
826

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban244$65,021
Trelegy ElliptaFluticasone/Umeclidin/Vilanter91$41,052
OzempicSemaglutide38$38,624
XareltoRivaroxaban86$28,135
TrulicityDulaglutide32$27,064
JanuviaSitagliptin Phosphate85$24,868
RexultiBrexpiprazole20$24,329
MyrbetriqMirabegron74$22,055
NuedextaDextromethorphan Hbr/Quinidine26$19,742
MounjaroTirzepatide21$18,698
FarxigaDapagliflozin Propanediol51$18,342
JardianceEmpagliflozin36$11,183
Mesalamine12$10,892
Quetiapine Fumarate ErQuetiapine Fumarate18$10,238
LinzessLinaclotide16$9,991

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$96$65,021244 claims
Lilly USA, LLCTrulicity, Mounjaro$187$45,76253 claims
Novo NordiskOzempic$207$38,62438 claims
Johnson & JohnsonXarelto$34$28,13586 claims
MerckJanuvia$28$24,86885 claims
AstraZenecaFarxiga, Symbicort$14$24,66176 claims
Otsuka America Pharmaceutical, Inc.Rexulti$34$24,32920 claims
Astellas Pharma US IncMyrbetriq$127$22,05574 claims
Avanir Pharmaceuticals, Inc.Nuedexta$16$19,74226 claims
Boehringer IngelheimJardiance$20$11,18336 claims
AbbVieLinzess$48$9,99116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Fayette

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →